Cart summary

You have no items in your shopping cart.

VPC-13789

SKU: orb1688383

Description

VPC-13789 is a potent, selective, and orally bioavailable antiandrogen, demonstrating promise for castration-resistant prostate cancer (CRPC) research. It inhibits androgen receptor transcriptional activity in LNCaP cells with an IC50 of 0.19 µM. Its profile supports investigation in both in vitro mechanistic studies and in vivo xenograft models for therapeutic development.

Research Area

Metabolism Research

Images & Validation

Key Properties

CAS Number2761146-51-2
MW383.37
FormulaC21H16F3N3O
SMILESFC1=C2C(C(=CN2)C3=NC4=C(C=C3)C(C(NC(C)C)=O)=CC=C4)=CC(F)=C1F
TargetAndrogen Receptor,Others

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

VPC-13789 (orb1688383)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%